Mulmit

CervoMed Inc.CervoMed Inc.

CRVO Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-314,006,510-28,294,877-26,970,000
2024-12-319,737,974-18,227,131-16,290,000
2023-12-317,144,872-7,812,895-2,170,000
2022-12-310-3,475,534-5,803,0472,038,891
2012-12-31374,542-11,791,869-6,868,894

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-06-11BOGER JOSHUA S955,414
2026-06-11BOGER JOSHUA S955,414
2026-06-11BOGER JOSHUA S955,414
2026-06-08ZAVRL FRANK8,150
2026-06-08Sabbagh Marwan8,150
2026-06-08Quigley David8,150
2026-06-08Poulton Jeffrey V.8,150
2026-06-08Hollingsworth Jane H8,150
2026-06-08Gregoire Sylvie8,150
2026-06-08BOGER JOSHUA S8,150
2026-06-08ALAM JOHN JCEO & President8,150
2026-02-11Winton MatthewChief Commercial and Business30,000

8-K events

FiledItems
2026-08-10Results of operations · Financial statements and exhibits
2026-08-04Regulation FD disclosure · Other events · Financial statements and exhibits
2026-07-14Regulation FD disclosure · Other events · Financial statements and exhibits
2026-07-09Regulation FD disclosure · Other events · Financial statements and exhibits
2026-06-22Regulation FD disclosure · Other events · Financial statements and exhibits
2026-06-22Entry into a material agreement · Unregistered sales of equity securities · Other events · Financial statements and exhibits
2026-06-18Other events · Financial statements and exhibits
2026-06-15Regulation FD disclosure · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Pharmaceutical Preparations — 같은 업종, 그리고 규모가 비슷한 기업Pharmaceutical Preparations — and other companies of a similar size

SEC가 같은 업종(Pharmaceutical Preparations)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Pharmaceutical Preparations) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.